Entellus Medical (ENTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,621 | -16,381 | -8,338 | -28,730 | -21,412 |
| Depreciation Amortization | 4,201 | 1,624 | 811 | 2,579 | 1,470 |
| Income taxes - deferred | -14,876 | 6 | 3 | 6 | 34 |
| Accounts receivable | -3,448 | -2,400 | -205 | -3,212 | -1,454 |
| Accounts payable and accrued liabilities | -235 | 207 | -236 | 596 | 1,834 |
| Other Working Capital | -5,753 | -3,764 | -3,954 | 48 | 2,089 |
| Other Operating Activity | 12,831 | 6,031 | 2,251 | 8,642 | 4,156 |
| Operating Cash Flow | $-26,901 | $-14,677 | $-9,668 | $-20,071 | $-13,283 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 10,837 | 10,837 | 7,837 | 27,257 | 14,157 |
| PPE Investments | -2,603 | -1,389 | -622 | -3,992 | -3,469 |
| Net Acquisitions | -24,778 | N/A | N/A | -11,000 | -11,000 |
| Investing Cash Flow | $-16,544 | $9,448 | $7,215 | $12,265 | $-312 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 48,145 | 28,268 | 8,000 | N/A | 0 |
| Debt Issued | 40,000 | 13,500 | 13,500 | N/A | 0 |
| Debt Repayment | -20,000 | -20,000 | -20,000 | N/A | 0 |
| Common Stock Issued | 46,983 | 46,487 | 46,030 | 234 | 372 |
| Common Stock Repurchased | N/A | N/A | -18 | N/A | N/A |
| Other Financing Activity | -41,540 | -21,611 | -1,301 | 548 | 0 |
| Financing Cash Flow | $73,588 | $46,644 | $46,211 | $782 | $372 |
| Exchange Rate Effect | -108 | 40 | 14 | -107 | -89 |
| Beginning Cash Position | 21,417 | 21,417 | 21,417 | 28,548 | 28,548 |
| End Cash Position | 51,452 | 62,872 | 65,189 | 21,417 | 15,236 |
| Net Cash Flow | $30,035 | $41,455 | $43,758 | $-7,131 | $-13,312 |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,901 | -14,677 | -9,668 | -20,071 | -13,283 |
| Capital Expenditure | -2,603 | -1,389 | -622 | -3,993 | -3,469 |
| Free Cash Flow | -29,504 | -16,066 | -10,290 | -24,064 | -16,752 |